2 届 ESMO 肺癌共识会议：局部晚期 III 期非小细胞肺癌。
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.
机构信息
Department of Medical Oncology, West German Cancer Centre, University Hospital, University Duisburg-Essen, Ruhrlandklinik, Essen, Germany.
Department of Radiation Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, Leuven, Belgium.
出版信息
Ann Oncol. 2015 Aug;26(8):1573-88. doi: 10.1093/annonc/mdv187. Epub 2015 Apr 20.
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on locally advanced disease.
为了补充所有肿瘤类型的现有治疗指南，ESMO 组织共识会议，专注于每种肿瘤类型的具体问题。第二届 ESMO 肺癌共识会议于 2013 年 5 月 11 日至 12 日在卢加诺举行。共有 35 名专家出席会议，讨论了非小细胞肺癌（NSCLC）在四个领域的几个问题：病理学和分子生物标志物、晚期疾病的一线/二线和进一步治疗、早期疾病和局部晚期疾病。针对每个问题，都提出了建议，包括推荐等级和证据水平。本文主要关注局部晚期疾病。
Zotero 插件